Indegene Ltd Stock Hits All-Time Low Amidst Prolonged Downtrend

Recent Price Movement and Market Context

On the day of 13 Mar 2026, Indegene Ltd’s share price fell by 1.45%, closing at ₹436.90, underperforming the Sensex which declined by 0.77%. This drop extended a losing streak that has persisted for 10 consecutive trading days, during which the stock has shed 12.2% of its value. The current price is just 0.35% above its 52-week low of ₹438.45, underscoring the severity of the downtrend.

The stock’s performance over various time frames highlights sustained weakness relative to benchmark indices. Over the past three months, Indegene has declined by 16.95%, compared to an 11.52% fall in the Sensex. Year-to-date, the stock is down 16.07%, lagging the Sensex’s 11.47% decline. Over the last year, the stock has lost 15.33%, while the Sensex has gained 2.19%. Notably, the company’s three- and five-year returns stand at 0.00%, significantly trailing the Sensex’s 29.55% and 48.54% gains respectively. The ten-year return also remains flat at 0.00%, compared to the Sensex’s 205.22% rise.

Technically, Indegene is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — reinforcing the bearish trend. The overall technical outlook is classified as bearish since 2 Mar 2026, with multiple indicators such as MACD, Bollinger Bands, KST, and Dow Theory signalling downward momentum. Immediate support is at the 52-week low of ₹438.45, while resistance levels are identified at ₹475.94 (20-day moving average), ₹507.68 (100-day moving average), and ₹539.28 (200-day moving average).

Valuation and Financial Metrics

Indegene Ltd is classified as a small-cap company with a market capitalisation grade reflecting this status. The stock’s valuation multiples as of 13 Mar 2026 include a price-to-earnings (P/E) ratio of 24x and a price-to-book value (P/BV) of 3.74x, indicating a premium valuation relative to its peers. The enterprise value to EBITDA ratio stands at 15.88x, while the EV to EBIT ratio is 19.24x. The PEG ratio is 1.71x, suggesting moderate valuation in relation to earnings growth.

Dividend metrics reveal a modest dividend yield of 0.45%, with the latest dividend declared at ₹2 per share and a payout ratio of 11.78%. The ex-dividend date was 13 Jun 2025.

Financial Performance and Growth Trends

Despite the stock’s price decline, Indegene reported positive quarterly results in December 2025. Net sales reached a record ₹942.10 crores, while PBDIT (profit before depreciation, interest, and taxes) also hit a high of ₹159.50 crores. These figures indicate operational strength in recent quarters.

However, the company’s long-term growth rates have been moderate. Over the past five years, net sales have grown at an annualised rate of 13.14%, with operating profit increasing at 13.41% annually. This growth is considered below par when compared to broader market expectations and sector benchmarks.

Profitability metrics show a return on equity (ROE) of 15.56%, reflecting efficient management and capital utilisation. The company maintains a strong balance sheet with negligible debt, evidenced by an average debt-to-equity ratio of zero and net cash position. The average return on capital employed (ROCE) is robust at 41.32%, further underscoring financial discipline.

Quality and Risk Assessment

Indegene is rated as a good quality company based on long-term financial performance. Management risk is assessed as good, and the capital structure is excellent due to minimal leverage. The company has no promoter share pledging, and institutional holdings stand at a moderate 19.55%. Tax ratio averages 22.87%, and dividend payout remains conservative.

Despite these strengths, the stock’s performance relative to the BSE500 index has been disappointing. It has underperformed over the last three years, one year, and three months, reflecting challenges in translating financial quality into market returns.

Trading Volumes and Market Interest

Delivery volumes have shown notable changes recently. The one-month delivery volume increased by 103.43%, while the one-day delivery volume rose by 39.03% compared to the five-day average. However, average daily volumes over the trailing month have declined from 3.45 lakh shares to 1.55 lakh shares on 12 Mar 2026, representing 52.85% of total volume, down from previous averages. This suggests fluctuating market participation amid the price decline.

Summary of Key Technical Levels

The immediate support level is at the 52-week low of ₹438.45, which the stock recently tested. Resistance levels are positioned at ₹475.94, ₹507.68, and ₹539.28, corresponding to the 20-day, 100-day, and 200-day moving averages respectively. The 52-week high remains at ₹632.10, a distant level given the current price trajectory.

Conclusion

Indegene Ltd’s stock has reached an all-time low amid a sustained downtrend that has persisted over multiple months. While the company demonstrates solid financial quality, including strong returns on capital and a healthy balance sheet, its market performance has lagged significantly behind benchmark indices and sector peers. The recent quarterly results show operational strength, but the stock’s valuation and price action reflect investor caution. The technical indicators and moving averages suggest continued bearish momentum in the near term.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →